tailieunhanh - Adjuvant immunotherapy recommendations for stage III melanoma: Physician and nurse interviews

Adjuvant immunotherapy is revolutionising care for patients with resected stage III and IV melanoma. However, immunotherapy may be associated with toxicity, making treatment decisions complicated. This study aimed to identify factors physicians and nurses considered regarding adjuvant immunotherapy for melanoma. |

TÀI LIỆU LIÊN QUAN
TỪ KHÓA LIÊN QUAN